AI-Powered Biotech Startup Archon Raises $20M
Archon Biosciences emerges from stealth with $20M in seed funding to revolutionize antibody treatments using AI-designed protein 'cages'.
BioTech
Colossal Biosciences Raises $200M at $10.2B Valuation to Bring Back Extinct Species
Colossal Biosciences secures massive funding to revive woolly mammoths, Tasmanian tigers, and dodo birds, with potential applications in human healthcare and agtech.
Cradle Raises $73 Million to Accelerate Biotech with AI-Driven Protein Design
Cradle, a biotech startup leveraging AI for protein design, secures $73 million in funding to expand its labs and team, aiming to put its software in the hands of a million scientists.
Dimension Capital Raises Oversubscribed $500 Million Fund, Defying Industry Trends
Dimension Capital, a two-year-old VC firm, announces a successful $500 million fundraise, bucking the trend of a challenging year for venture capital fundraising.
OpenAI CEO Sam Altman Invests $1 Billion in Retro Biosciences to Extend Human Lifespan
OpenAI CEO Sam Altman joins $1 billion Series A funding round for Retro Biosciences, a biotech startup aiming to increase human lifespan by 10 years.
UK Startup Deep Blue Biotech Revolutionizes Chemical Production with Photosynthesis-Based Biomanufacturing
Deep Blue Biotech, a UK-based startup, is pioneering a novel approach to chemical production using photosynthesis-based biomanufacturing, promising cost-effective and environmentally friendly alternatives to traditional methods.
New Venture Fund Aims to Fill NIH Funding Gap for Biotech Startups
Altitude Lab Pre-seed Venture Fund to invest in 10-15 biotech companies, bridging potential NIH funding gap for early-stage startups
Michigan Biotech Startup CircNova Raises $3.3M Seed Round for AI-Driven Circular RNA Therapies
CircNova, a Michigan-based biotech startup, has secured $3.3 million in seed funding for its AI-powered technology targeting circular RNA, a newly discovered class of RNA structures with potential to treat complex health issues.
Afynia Laboratories Secures $5 Million in Seed Funding to Commercialize Blood Test for Endometriosis
Canadian biotech startup Afynia Laboratories raises $5 million to develop a non-invasive blood test for endometriosis, a medical condition affecting nearly 200 million people worldwide.